Brandariz Lorena, Arriba María, García Juan Luis, Cano Juana María, Rueda Daniel, Rubio Eduardo, Rodríguez Yolanda, Pérez Jessica, Vivas Alfredo, Sánchez Carmen, Tapial Sandra, Pena Laura, García-Arranz Mariano, García-Olmo Damián, Urioste Miguel, González-Sarmiento Rogelio, Perea José
Surgery Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
Biochemistry Department, Gregorio Marañón University Hospital, Madrid, Spain.
Oncotarget. 2018 Feb 15;9(20):15302-15311. doi: 10.18632/oncotarget.24502. eCollection 2018 Mar 16.
Since there is a predilection of some clinical and molecular features for a given tumor location, we assessed whether this can be confirmed in late-onset colorectal cancer (LOCRC).
Right colon cancers showed features associated with sporadic Microsatellite Instability: predominance of female cases and mutations, and an important mucinous component. Left colon cancers developed a higher number of polyps and multiple primary CRCs, showed the strongest familial component, and had better prognosis. Rectal cancers showed a predominantly sporadic phenotype, with worse prognosis and a CpG Island Methylator Phenotype (CIMP)-High. No copy number alterations (CNAs) greater than or equal to 50% were observed in this LOCRC group, and the most recurrent alterations were losses at 5q13 and 14q11, and gains at 7q11, 7q21-q22, 19p13-p12, 19q13 and 20p11-q11. and were the only mutated genes showing differences according to the tumor location, mainly for right colon cancers.
We analyzed clinical and molecular characteristics of LOCRC at different tumor locations in order to determine if there are differential phenotypes related with the location in the colon.
Categorizing LOCRC according to tumor location appears to be an adequate first step to resolving the heterogeneity of this subset of CRC.
由于某些临床和分子特征在特定肿瘤位置存在偏好性,我们评估了这一点在晚期结直肠癌(LOCRC)中是否能够得到证实。
右半结肠癌表现出与散发性微卫星不稳定相关的特征:女性病例占优势、存在突变以及重要的黏液成分。左半结肠癌发生息肉和多原发性结直肠癌的数量更多,显示出最强的家族性成分,且预后较好。直肠癌表现出主要为散发性的表型,预后较差且为高甲基化表型(CIMP)。在该LOCRC组中未观察到大于或等于50%的拷贝数改变(CNA),最常见的改变是5q13和14q11缺失,以及7q11、7q21 - q22、19p13 - p12、19q13和20p11 - q11增益。 和 是仅有的根据肿瘤位置显示出差异的突变基因,主要见于右半结肠癌。
我们分析了不同肿瘤位置的LOCRC的临床和分子特征,以确定结肠中是否存在与位置相关的差异表型。
根据肿瘤位置对LOCRC进行分类似乎是解决这一结直肠癌亚组异质性的适当第一步。